Labcorp Holdings (LH) Cost of Revenue (2009 - 2026)

Labcorp Holdings (LH) has 18 years of Cost of Revenue data on file, last reported at $2.5 billion in Q1 2026.

• Quarterly Cost of Revenue rose 5.29% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 billion (up 5.93% YoY) and the FY2025 annual result came in at $9.9 billion, up 5.91% from the prior year.
• Cost of Revenue steadied at $2.5 billion in Q1 2026 per LH's latest filing, from $2.5 billion in the prior quarter.
• The five-year high for Cost of Revenue was $2.7 billion in Q1 2022, with the low at $2.0 billion in Q2 2022.
• Average Cost of Revenue over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2024.
• The widest YoY moves for Cost of Revenue: up 549.48% in 2022, down 26.02% in 2022.
• Labcorp Holdings' Cost of Revenue stood at $2.1 billion in 2022, then grew by 3.77% to $2.2 billion in 2023, then gained by 10.0% to $2.4 billion in 2024, then grew by 3.68% to $2.5 billion in 2025, then advanced by 0.05% to $2.5 billion in 2026.
• Business Quant data shows LH's Cost of Revenue at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.